Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of fiber gelatinized protein 3

A technology of colloidal gold test paper and diabetes, which is applied in the application field of protein molecular markers, and can solve the problems such as no reports on the correlation of diabetic nephropathy

Active Publication Date: 2014-03-05
SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI +2
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] But so far, there is no report on the correlation between ficolin 3 and diabetes and diabetic nephropathy in the existing literature

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of fiber gelatinized protein 3
  • Application of fiber gelatinized protein 3
  • Application of fiber gelatinized protein 3

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0021] Example 1 , normal healthy controls and the preparation of serum samples from patients with type 2 diabetes mellitus

[0022] Sodium phosphate used in this example was purchased from Sigma Company, formic acid was purchased from Fluka Company, and acetonitrile was purchased from Merck Company.

[0023] Serum samples from normal healthy controls and patients with type 2 diabetes were provided by the Diabetes Institute of Shanghai Sixth People's Hospital, and the protein concentration in the original plasma was quantified by the Bradford method to be about 100 mg / mL.

[0024] The original serum was diluted to 20 mg / mL with 50 mM sodium phosphate buffer solution (pH 2.5, containing 5% acetonitrile), and passed through a 0.22 μm filter membrane at room temperature at a speed of 10,000 g / min. The resulting solution was replaced by dialysis into solution A of strong cation exchange chromatography, namely 50 mM sodium phosphate buffer solution (pH 2.5, containing 5% acetonit...

Embodiment 2

[0030] Example 2 1. Screening method for differentially expressed proteins

[0031] Dithiothreitol (DTT) used in this example was purchased from Sigma; iodoacetamide (IAA) and formic acid were purchased from Fluka; acetonitrile was purchased from Merck; capillary reversed-phase liquid chromatography was purchased from Agilent.

[0032] The composition of the loading buffer used was: 0.6 mL of 1 mol / L Tris-HCl (pH6.8), 5 mL of 50% glycerol, 2 mL of 10% SDS, 0.5 mL of mercaptoethanol, 1.9 mL of distilled water, and a small amount of bromophenol blue.

[0033] Take equal amounts of 1.8 mg of mixed serum samples from diabetic patients and normal healthy controls (from 5 individuals each), add 1 μL 1M DTT to them, and place them at 56°C for 30 min. After cooling to room temperature, add 5 μL 1M IAA, Store at room temperature in the dark for 40 minutes.

[0034] The above-mentioned treated plasma samples were separated by one-dimensional gel electrophoresis (7.5-17.5% gradient ge...

Embodiment 3

[0058] Example 3 , Screening method for differentially expressed proteins 2

[0059] Dithiothreitol (DTT) used in this example was purchased from Sigma; iodoacetamide (IAA) and formic acid were purchased from Fluka; acetonitrile was purchased from Merck; capillary reversed-phase liquid chromatography was purchased from Agilent.

[0060] Add 250 μL solution (100 mM NaCl, 10 mM HEPES, pH 7.4) to 50 μL serum sample, use a 0.22 μm filter membrane to remove lipid by centrifugation at 10 000 g at 4°C; take 260 μL lipid-free serum sample and add 182 μL cold ethanol solution , placed on a vertical shaker at 4°C for 1 h, and then centrifuged at 16 000 g for 45 min at 4°C. The supernatant is the high-abundance component, and the precipitated part is the low-abundance component.

[0061] Both components were lyophilized, and then 200 μL of 2D lysate was added for dissolution. Take 100 μL of high-abundance and low-abundance fractions, add 1 μL 1M DTT, mix well, place at 37°C for 2.5 h...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a relation among fiber gelatinized protein 3, diabetes mellitus and diabetic nephropathy and accordingly provides an application of the fiber gelatinized protein 3 as a proteinmolecular marker for detecting diabetes mellitus and diabetic nephropathy or forecasting diabetic nephropathy in early stage and a method of using an antibody of the fiber gelatinized protein 3 to de tect the expression condition of the fiber gelatinized protein 3 in blood serum. Due to the relativity among the fiber gelatinized protein 3, type-2 diabetes mellitus and the diabetic nephropathy, theprotein can be used for detecting the protein molecular markers of the type-2 diabetes mellitus and the diabetic nephropathy and is in high expression in the blood serum of sufferers of diabetes mell itus and diabetic nephropathy, and detection products prepared by the protein have fine detection effect.

Description

technical field [0001] The invention belongs to the field of biotechnology, in particular, the invention relates to the application of ficolin 3 as a protein molecular marker for detecting diabetes and diabetic nephropathy. Background technique [0002] Diabetes is a disease that seriously threatens human health. The morbidity and mortality of diabetes are on the rise in developing countries. China has become the hardest-hit area for diabetes, and the annual medical expenditure for diabetes treatment has increased greatly, which shows that diabetes has become an enemy that seriously endangers the safety of people's lives and property in our country, and is an important factor affecting social and economic development. Therefore, more efforts should be made to It is of strategic significance to conduct basic research on diabetes in my country. [0003] For diabetic patients, early detection, early diagnosis and early treatment of diabetes are the key to their recovery. To ach...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N33/68G01N33/577G01N33/543
Inventor 曾嵘贾伟平吴家睿谢佳辉陈海冰李荣霞严中华
Owner SHANGHAI INST OF BIOLOGICAL SCI CHINESE ACAD OF SCI